These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1694826)

  • 21. Comparison of heat-labile enterotoxins from porcine and human strains of Escherichia coli.
    Geary SJ; Marchlewicz BA; Finkelstein RA
    Infect Immun; 1982 Apr; 36(1):215-20. PubMed ID: 6176542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping epitopic regions of cholera toxin B-subunit protein.
    Kazemi M; Finkelstein RA
    Mol Immunol; 1991 Aug; 28(8):865-76. PubMed ID: 1715029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of an enterotoxin produced by Vibrio cholerae O139.
    Nakashima K; Eguchi Y; Nakasone N
    Microbiol Immunol; 1995; 39(2):87-94. PubMed ID: 7783690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of hybridoma cell lines and characterization of monoclonal antibodies against cholera enterotoxin and its subunits.
    Robb M; Nichols JC; Whoriskey SK; Murphy JR
    Infect Immun; 1982 Oct; 38(1):267-72. PubMed ID: 6183210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization of heat-labile toxin of E. coli by antibodies to synthetic peptides derived from the B subunit of cholera toxin.
    Jacob CO; Pines M; Arnon R
    EMBO J; 1984 Dec; 3(12):2889-93. PubMed ID: 6098453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro.
    Apter FM; Lencer WI; Finkelstein RA; Mekalanos JJ; Neutra MR
    Infect Immun; 1993 Dec; 61(12):5271-8. PubMed ID: 7693598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nontoxic cholera enterotoxin (CT) analog is chimeric with regard to both epitypes of CT-B subunits, CT-B-1 and CT-B-2.
    Boesman-Finkelstein M; Peterson JW; Thai LS; Finkelstein RA
    Infect Immun; 1996 Jan; 64(1):346-8. PubMed ID: 8557362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochromatographic detection of the heat-labile enterotoxin of enterotoxigenic Escherichia coli with cross-detection of cholera toxin.
    Arimitsu H; Sasaki K; Tsuji T
    J Microbiol Methods; 2017 Jan; 132():148-152. PubMed ID: 27940044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enterotoxin-specific immunoglobulin E responses in humans after infection or vaccination with diarrhea-causing enteropathogens.
    Qadri F; Asaduzzaman M; Wennerås C; Mohi G; Albert MJ; Abdus Salam M; Sack RB; Jertborn M; McGhee JR; Sack DA; Holmgren J
    Infect Immun; 2000 Oct; 68(10):6077-81. PubMed ID: 10992527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of polyclonal and monoclonal antibody responses to cholera toxin by the synthetic peptide approach.
    Ghose AC; Karush F
    Mol Immunol; 1988 Mar; 25(3):223-30. PubMed ID: 3374493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleotide sequence analysis of the A2 and B subunits of Vibrio cholerae enterotoxin.
    Lockman H; Kaper JB
    J Biol Chem; 1983 Nov; 258(22):13722-6. PubMed ID: 6315707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological similarity of enterotoxins of Vibrio cholerae serotypes other than type 1 to cholera toxin and Escherichia coli heat-labile enterotoxin.
    Lahiri A; Agarwal RK; Sanyal SC
    J Med Microbiol; 1982 Nov; 15(4):429-40. PubMed ID: 6757437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological differences among the cholera/coli family of enterotoxins.
    Marchlewicz BA; Finkelstein RA
    Diagn Microbiol Infect Dis; 1983 Jun; 1(2):129-38. PubMed ID: 6201315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies with an expanded repertoire of specificities and potent neutralizing activity for Escherichia coli heat-labile enterotoxin.
    Belisle BW; Twiddy EM; Holmes RK
    Infect Immun; 1984 Dec; 46(3):759-64. PubMed ID: 6209224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the Chinese hamster ovary cell assay for the enterotoxins of Vibrio cholerae and Escherichia coli and for specific antisera, and toxoid.
    Guerrant RL; Brunton LL
    J Infect Dis; 1977 May; 135(5):720-8. PubMed ID: 323378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.
    Clements JD; Finkelstein RA
    Infect Immun; 1978 Sep; 21(3):1036-9. PubMed ID: 361573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bovine lactogenic immunity against cholera toxin-related enterotoxins and Vibrio cholerae outer membranes.
    Boesman-Finkelstein M; Walton NE; Finkelstein RA
    Infect Immun; 1989 Apr; 57(4):1227-34. PubMed ID: 2925248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro production of toxin-coregulated pili by Vibrio cholerae El Tor.
    Voss E; Attridge SR
    Microb Pathog; 1993 Oct; 15(4):255-68. PubMed ID: 7906005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological study of the heat-labile enterotoxins of Escherichia coli and Vibrio cholerae.
    Gyles CL
    Infect Immun; 1974 Mar; 9(3):564-70. PubMed ID: 4206029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.